Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation

被引：34
|
作者：
Inada, A
Nakanishi, T
Tokuda, H
Nishina, H
Iwashima, A
Sharma, OP
机构：
[1] KYOTO PREFECTURAL UNIV MED, KAMIGYO KU, KYOTO 607, JAPAN
[2] INDIAN VET RES INST, BIOCHEM LAB, REG STN, PALAMPUR 176061, HIMACHAL PRADES, INDIA
来源：
PLANTA MEDICA | 1995年 / 61卷 / 06期
关键词：
D O I：
10.1055/s-2006-959371
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
To search for possible antitumor promoters, inhibitory effects of lantadenes and related triterpenoids from Lantana camara L. (Verbenaceae) on Epstein-Barr virus activation, were tested. The substitutions on the carboxylic acid through an ester bond might play an important role in the activity.
引用
收藏
页码：558 / 559
页数：2
相关论文
共 50 条
  • [41] Stress-related Epstein-Barr virus reactivation
    Coskun, Omer
    Sener, Kenan
    Kilic, Selim
    Erdem, Hakan
    Yaman, Halil
    Besirbellioglu, Ahmet Bulent
    Gul, Hanefi Cem
    Eyigun, Can Polat
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (01) : 15 - 20
  • [42] Immunotherapy for Epstein-Barr Virus-Related Lymphomas
    Kennedy-Nasser, Alana A.
    Bollard, Catherine M.
    Heslop, Helen E.
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2009, 1 (02)
  • [43] Issues related to development of Epstein-Barr virus vaccines
    Spring, SB
    Hascall, G
    Gruber, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) : 1436 - 1441
  • [44] Epstein-Barr virus vectors for the treatment of Epstein-Barr virus-associated cancers
    Paillard, F
    [J]. HUMAN GENE THERAPY, 1998, 9 (08) : 1119 - 1120
  • [45] Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection
    Bauer, CC
    Aberle, SW
    Popow-Kraupp, T
    Kapitan, M
    Hofmann, H
    Puchhammer-Stöckl, E
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (01) : 54 - 58
  • [46] Inhibitory effects of fatty acid monoesters of 2-O-β-D-glucosylglycerol on Epstein-Barr virus activation
    Colombo, D
    Scala, A
    Taino, IM
    Toma, L
    Ronchetti, F
    Tokuda, H
    Nishino, H
    Nagatsu, A
    Sakakibara, J
    [J]. CANCER LETTERS, 1998, 123 (01) : 83 - 86
  • [47] Inhibitory effects of monoacylated 2-O-β-galactosylglycerols on Epstein-Barr virus activation:: the significant role of the hexanoyl chain
    Colombo, D
    Compostella, F
    Ronchettia, F
    Scala, A
    Toma, L
    Mukainaka, T
    Nagatsu, A
    Konoshima, T
    Tokuda, H
    Nishino, H
    [J]. CANCER LETTERS, 1999, 143 (01) : 1 - 4
  • [48] CYTOLYTIC VIRUS ACTIVATION THERAPY FOR EPSTEIN-BARR VIRUS DRIVEN TUMOURS
    Greijer, A. E.
    Stoker, S. D.
    Novalic, Z.
    Malik, O.
    Verkuijlen, S. A. W. M.
    Juwana, H.
    Huitema, A. D. R.
    Tan, B. I.
    de Boer, J. P.
    Hutajulu, S. H.
    Kurnianda, J.
    Middeldorp, J. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : E44 - E44
  • [49] STUDIES ON INHIBITORS OF SKIN TUMOR PROMOTION .6. INHIBITORY EFFECTS OF QUINONES ON EPSTEIN-BARR VIRUS-ACTIVATION
    KONOSHIMA, T
    KOZUKA, M
    KOYAMA, J
    OKATANI, T
    TAGAHARA, K
    TOKUDA, H
    [J]. JOURNAL OF NATURAL PRODUCTS, 1989, 52 (05): : 987 - 995
  • [50] INHIBITORY EFFECTS OF CUCURBITANE TRITERPENOIDS ON EPSTEIN-BARR-VIRUS ACTIVATION AND 2-STAGE CARCINOGENESIS OF SKIN TUMOR .2.
    KONOSHIMA, T
    TAKASAKI, M
    KOZUKA, M
    NAGAO, T
    OKABE, H
    IRINO, N
    NAKASUMI, T
    TOKUDA, H
    NISHINO, H
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1995, 18 (02) : 284 - 287
12345